Figures and data
Design of synthetic nanobody library and antigen expressing vector.
A. Schematic of synthetic nanobody library design. Nanobody sequences were inserted at the 5’ end of pIII sequence in the phagemid. Nanobody sequences contain constant framework (FR1-FR4) and randomized regions within the CDRs. The randomization in highly variable positions is indicated as asterisks (*). The frequencies of amino acids in the variable positions are indicated in the bar chart. The cysteine and methionine were eliminated from design to avoid chemical reactivity. The CDR3 region was designed with varying lengths (7, 11, or 15 residues).
B. Schematic of antigen expressing vector. Antigen expression was driven by an inducible metallothionein (MT) promoter. The antigen is fused to an N-terminal BiP signal peptide and FLAG-tag, as well as a C-terminal human Immunoglobulin G (hIgG) Fc domain. GFP-T2A-PuroR cassette is driven by Copia promoter for fluorescence labeling and antibiotics selection.
Nanobody screen for CARPB.
A. Schematic of nanobody screening. The mCherry-hIgG-coated plate was used for negative selection and the antigen-hIgG-coated plate was used for positive selection. Three iterative rounds of screening were performed for each antigen.
B. ELISA with polyclonal phages from three rounds of selection in CARPB screen campaign. The mCherry-hIgG and CARPB-hIgG were coated in decreasing amounts across different rows. The intensity of green color represents the ELISA signal strength.
C. ELISA with monoclonal phages from the third round of selection in CARPB screen campaign. 96 monoclonal phages were tested against mCherry-hIgG and CARPB-hIgG.
D. Predicted Aligned Error (PAE) map generated using AlphaFold-Multimer for the CARPB-NbCARPB-1H complex. Low PAE values, shown in blue, indicate accurate predictions for the interaction interfaces, depicted in the top right and bottom left quadrants. High Local Interaction Score (LIS) and interface TM-score (ipTM) values confirm the structural reliability of the interface.
E. Predicted 3D structure of the CARPB-NbCARPB-1H complex, showing the interaction interface. The region enclosed by the dotted box corresponds to the interaction interface visualized in panel F. Residues involved in the interaction (within 8 Å distance) are marked in red (CARPB) and green (NbCARPB-1H) in the structure and protein sequences. CDRs in the protein sequence are marked by boxes. The interaction predominantly occurs within these CDR regions.
F. Neighboring residues between CARPB and NbCARPB-1H, showing residues within a 5 Å distance. Cyan indicates residues of CARPB, and magenta indicates residues of NbCARPB-1H. Each residue is labeled with its residue name and number.
Immunostaining of membrane-tethered CARPB with nanobodies.
A. CARPB-expressing cells stained with nanobody-displaying phages. GFP signals mark cells expressing membrane-tethered CARPB. Nb.b201 phage, an irrelevant nanobody displaying phage, was used as negative control. BF, bright field.
B. CARPB-expressing cells stained with purified nanobodies. GFP signals label the cells expressing membrane tethered CARPB. Nb127D01 is an irrelevant nanobody used as negative control. BF, bright field.
Immunostaining and immunoblotting with NbMip-4G nanobody.
A. Immunostaining of Drosophila adult intestine with NbMip-4G nanobody.
B. Immunoblotting detection of Mip in Drosophila adult hemolymph with NbMip-4G nanobody. A nonspecific band is included as a loading control.
C. Predicted Aligned Error (PAE) map generated using AlphaFold-Multimer for the Mip-NbMip-4G complex. Low PAE values, shown in blue, indicate accurate predictions for the interaction interfaces, depicted in the top right and bottom left quadrants. High LIS and ipTM values confirm the structural reliability of the interface.
D. Predicted 3D structure of the Mip-NbMip-4G complex. The surface representation shows NbMip-4G in green and the interacting helical segment of Mip (residues 42-62) in red. Key residues involved in the interaction are marked in red (Mip) and green (NbMip-4G) in the protein sequences. CDRs in the protein sequence are marked by boxes. The interaction predominantly occurs within these CDR regions.
E. Neighboring residues between Mip and NbMip-4G, showing residues within a 5 Å distance. Cyan indicates residues of Mip, and magenta indicates residues of NbMip-4G. Each residue in NbMip-4G is labeled with its residue name and number.
Nanobody screen for Mip.
A. ELISA with polyclonal phages from three rounds of selection in Mip screen campaign. The mCherry-hIgG and Mip-hIgG were coated in decreasing amounts across different rows. The intensity of green color represents the ELISA signal strength.
B. ELISA with monoclonal phages from the third round of selection in Mip screen campaign. 96 monoclonal phages were tested against mCherry-hIgG and Mip- hIgG.
C. Mip-expressing cells stained with nanobody-displaying phages. GFP signals mark cells expressing membrane-tethered Mip. Nb.b201 phage, an irrelevant nanobody displaying phage, was used as negative control. BF, bright field.
D. Mip-expressing cells stained with purified nanobodies. GFP signals label the cells expressing membrane-tethered Mip. Nb127D01 is an irrelevant nanobody used as negative control. BF, bright field.
Nanobody screen for Nesfatin-1.
A. ELISA with polyclonal phages from three rounds of selection in Nesfatin-1 screen campaign. The mCherry-hIgG and Nesfatin1-hIgG were coated in decreasing amounts across different rows. The intensity of green color represents the ELISA signal strength.
B. ELISA with monoclonal phages from the third round of selection in Nesfatin1 screen campaign. 48 monoclonal phages were tested against mCherry-hIgG and Nesfatin1-hIgG.
C. Nesfatin1-expressing cells stained with nanobody-displaying phages. GFP signals mark cells expressing membrane-tethered Nesfatin-1. Nb.b201 phage, an irrelevant nanobody displaying phage, was used as negative control. BF, bright field.
D. Nesfatin1-expressing cells stained with purified nanobodies. GFP signals label the cells expressing membrane-tethered Nesfatin-1. Nb127D01 is an irrelevant nanobody used as negative control. BF, bright field.
Nanobody screen for CG9849.
A. ELISA with polyclonal phages from three rounds of selection in CG9849 screen campaign. The mCherry-hIgG and CG9849-hIgG were coated in decreasing amounts across different rows. The intensity of green color represents the ELISA signal strength.
B. ELISA with monoclonal phages from the third round of selection in CG9849 screen campaign. 144 monoclonal phages were tested against mCherry-hIgG and CG9849-hIgG.
C. CG9849-expressing cells stained with nanobody-displaying phages. GFP signals mark cells expressing membrane-tethered CG9849. Nb.b201 phage, an irrelevant nanobody displaying phage, was used as negative control. BF, bright field.
D. CG9849-expressing cells stained with purified nanobodies. GFP signals label the cells expressing membrane-tethered CG9849. Nb127D01 is an irrelevant nanobody used as negative control. BF, bright field.
Nanobody screen for Amn.
A. ELISA with polyclonal phages from three rounds of selection in Amn screen campaign. The mCherry-hIgG and Amn-hIgG were coated in decreasing amounts across different rows. The intensity of green color represents the ELISA signal strength.
B. ELISA with monoclonal phages from the third round of selection in Amn screen campaign. 96 monoclonal phages were tested against mCherry-hIgG and Amn- hIgG.
Failed nanobody screens for Sgsf, Miple1 and CG13965.
A. ELISA with monoclonal phages from the third round of selection in Sgsf screen campaign. 96 monoclonal phages were tested against mCherry-hIgG and Sgsf- hIgG.
B. ELISA with monoclonal phages from the third round of selection in Miple1 screen campaign. 96 monoclonal phages were tested against mCherry-hIgG and Miple1-hIgG.
C. ELISA assay with monoclonal phages from the third round of selection in CG13965 screen campaign. 96 monoclonal phages were tested against mCherry-hIgG and CG13965-hIgG.
